Sofosbuvir plus daclatasvir for post-transplant recurrent hepatitis C: Potent antiviral activity but no clinical benefit if treatment is given late

Authors

Keywords

Journal

Volume 46, Issue 10, Pages 923-927

Publisher

Elsevier BV

Online

2014-07-03

DOI

10.1016/j.dld.2014.06.004

Explore over 38,000 international journals covering a vast array of academic fields.

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now